Keytruda - Product Information
Presentations Available as below

1) Name of the medicinal product:
KEYTRUDA (100mg) 25 mg/mL concentrate for solution for infusion.

Active Ingredient:
One vial of 4 mL of concentrate contains 100 mg of pembrolizumab. Each mL of concentrate contains 25 mg of pembrolizumab.

Pack: 
4 mL of concentrate in a 10 mL Type I clear glass vial, with a coated grey chlorobutyl stopper and an aluminium seal with a dark blue coloured flip-off cap, containing 100 mg pembrolizumab.
Each carton contains one vial.

Marketing Authorisation Holder:
Merck Sharp & Dohme

2) Name of the medicinal product:

KEYTRUDA 50 mg powder for concentrate for solution for infusion.

Active Ingredient:

One vial of powder contains 50 mg of pembrolizumab.
After reconstitution, 1 mL of concentrate contains 25 mg of pembrolizumab.

Pack: 
15 mL Type I glass vial, with a grey bromobutyl stopper and an aluminium seal with an avocado coloured flip-off cap, containing 50 mg pembrolizumab.
Each carton contains one vial.

Marketing Authorisation Holder:
Merck Sharp & Dohme

Request A Quotation for Keytruda

For more information on the availability and pricing on Keytruda please kindly fill out the form below.

We are a Distributor of Specialty Pharmaceuticals located in London and licensed in the United Kingdom. Our objective is to provide secure access of special medicines to Health Providers in Latin America. 

SPL Pharma is licensed by the UK Medicines and Healthcare Regulatory Agency (MHRA) and complies with the Good Distribution Practice (GDP) of the European Union. 

Our Address
 

SPL Pharma
33 Cavendish Square
London
England
W1G 0PW

Call / Email Us
 

+44 (0) 207 182 4992  
spl@splpharma.co.uk

© 2016-2020 by Specialty Pharma of London LTD
Company Reg No: 10167709
WDA Licence: WDA(H)46315

UK Tel: +44 (0) 207 182 4992  
Brasil - Cel / Whatsapp: +55-11-96059-4029

spl@splpharma.co.uk

  • LinkedIn - Black Circle
  • Black Facebook Icon
  • Black Twitter Icon